Retina specialists are shifting from povidone iodine to chlorhexidine to prevent infections after eye injections. A new study ...
TipRanks on MSN
Sanofi’s New Study on SAR446597: A Potential Game-Changer for Age-related Macular Degeneration
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a Phase 1/2 clinical study titled ‘A Safety and ...
Please provide your email address to receive an email when new articles are posted on . NEW YORK — Anterior chamber paracentesis may be an effective option to reduce IOP spikes after intravitreal ...
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
Intravitreal RPCs showed positive effects on electroretinography, optomotor response, and contrast sensitivity in a rat model ...
Please provide your email address to receive an email when new articles are posted on . There are more options available than just the standard methods. Choices need to be made for every step of the ...
A new preclinical study titled "Intravitreal Transplantation of Retinal Progenitor Cells Improves Outcome Measures in a Rat ...
Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
Lumata Health, the company focused on ending preventable blindness with continuous ophthalmic care for people facing chronic eye disease, today announced the results of its new research report, ...
Application of topical anesthetic drops may be more effective at reducing pain caused by intravitreal injection, according to an OSN SuperSite report. Gregory R. Blaha, MD, PhD, one of the study’s ...
STOCKHOLM — Simple changes, like minimizing patient visits and reducing the use of nonsterile gloves, can make a big difference in the environmental impact of intravitreal injections without ...
Cystic Fibrosis Foundation to provide up to $11 million in additional funding to accelerate development of 4D-710 for cystic fibrosis, following ...
The current standards of care involve using anti-VEGF agents, which selectively target extracellular VEGF. We've been doing this for years and those drugs do a good job, but there are limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results